Third consensus on medical treatment of metastatic breast cancer

S. Beslija, J. Bonneterre, H. J. Burstein, V. Cocquyt, M. Gnant, V. Heinemann, J. Jassem, W. J. Köstler, M. Krainer, S. Menard, T. Petit, L. Petruzelka, K. Possinger, P. Schmid, E. Stadtmauer, M. Stockler, S. Van Belle, C. Vogel, N. Wilcken, C. WiltschkeChristoph C. Zielinski, H. Zwierzina

Research output: Contribution to journalReview articlepeer-review

146 Scopus citations


Background: Treatment options for patients with metastatic breast cancer (MBC) include a rapidly expanding repertoire of medical, surgical and supportive care measures. Design: To provide timely and evidence-based recommendations for the diagnostic workup and treatment of patients with MBC, an international expert panel reviewed and discussed the evidence available from clinical trials regarding diagnostic, therapeutic and supportive measures with emphasis on their impact on the quality of life and overall survival of patients with MBC. Results: Evidence-based recommendations for the diagnostic workup, endocrine therapy, chemotherapy, use of targeted therapies and bisphosphonates, surgical treatment and supportive care measures in the management of patients with MBC were formulated. Conclusions: The present consensus manuscript updates evidence-based recommendations for state-of-the-art treatment of MBC depending on disease-associated and biological variables.

Original languageEnglish (US)
Pages (from-to)1771-1785
Number of pages15
JournalAnnals of Oncology
Issue number11
StatePublished - 2009
Externally publishedYes


  • Diagnosis
  • Metastatic breast cancer
  • Prognosis
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Hematology


Dive into the research topics of 'Third consensus on medical treatment of metastatic breast cancer'. Together they form a unique fingerprint.

Cite this